Matches in Nanopublications for { ?s ?p "[Recent evidence indicates that certain genotypes of beta(2)-adrenoceptors (AR) may indicate an increased risk of cardiovascular disease or an increased rate of disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP841934.RAfgQs-tixgasqXIN9-50wLPkZbOriq5B8M9m6T4ZVwic130_assertion description "[Recent evidence indicates that certain genotypes of beta(2)-adrenoceptors (AR) may indicate an increased risk of cardiovascular disease or an increased rate of disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841934.RAfgQs-tixgasqXIN9-50wLPkZbOriq5B8M9m6T4ZVwic130_provenance.
- NP309304.RAmMynoEIbiEAo1lzpD478nhfdvacn69IDEDZzzvrOymc130_assertion description "[Recent evidence indicates that certain genotypes of beta(2)-adrenoceptors (AR) may indicate an increased risk of cardiovascular disease or an increased rate of disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309304.RAmMynoEIbiEAo1lzpD478nhfdvacn69IDEDZzzvrOymc130_provenance.
- NP587625.RAIROwa5Ah5Hq_PDm0XUOacZ5e23YWN-Trj7uaaGxlVLs130_assertion description "[Recent evidence indicates that certain genotypes of beta(2)-adrenoceptors (AR) may indicate an increased risk of cardiovascular disease or an increased rate of disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587625.RAIROwa5Ah5Hq_PDm0XUOacZ5e23YWN-Trj7uaaGxlVLs130_provenance.
- NP309303.RA6OMpoYSLFLoXHIFAGY-X08dAyKsVPFBQRrmCS3xzfWw130_assertion description "[Recent evidence indicates that certain genotypes of beta(2)-adrenoceptors (AR) may indicate an increased risk of cardiovascular disease or an increased rate of disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309303.RA6OMpoYSLFLoXHIFAGY-X08dAyKsVPFBQRrmCS3xzfWw130_provenance.